Skip to main content
  • No Early Sex Differences For TAVR Bravo 3 substudy suggests benefit for women on bivalirudin, though

    ORLANDO — Outcomes within 30 days were similar between sexes after transcatheter aortic valve replacement (TAVR) via transfemoral access, according to a late-breaking investigation presented here.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details